Skip to main content
Log in

Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria

  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Recent studies suggest that cytokines modulate bone turnover. Idiopathic hypercalciuria (IH) seems to be associated with bone mineral loss. Therefore, the aim of this study was to assess cytokines involved in bone turnover in patients with IH.

Methods

Plasma and spot-urine levels of interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor alpha (TNF-α), transforming growth factor β1 (TGF-β1), and monocyte chemoattractant protein (MCP-1) were measured in 70 children and adolescents with IH and in 37 healthy controls. Patients with IH were subdivided according to their calciuria at the time of sample collection: ≥4 mg/kg/day (persistent IH, n=27) and below 4 mg/kg/day (controlled IH, n=43). Cytokines were determined by enzyme-linked immunoassay.

Results

Plasma and urinary concentrations of IL-1β, IL-6, IL-8, and TNF-α were undetectable in all groups. No differences were found between controlled and persistent hypercalciuria for plasma and urinary levels of MCP-1 and TGF-β1. On the other hand, MCP-1 levels were significantly higher in both subgroups of IH in comparison to healthy controls. Furthermore, urinary MCP-1 levels of IH patients correlated positively with bone mineral content (p=0.013).

Conclusion

Although cytokine measurements did not allow the differentiation between persistent and controlled IH, our findings suggest that MCP-1 might play a role in patients with IH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Albright F, Henneman P, Benedict PH, Forbes AP (1953) Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med 46:1077–1081

    PubMed  CAS  Google Scholar 

  2. Ammenti A, Neri E, Agistri R, Beseghi U, Bacchini E (2006) Idiopathic hypercalciuria in infants with renal stones. Pediatr Nephrol 21:1901–1903

    Article  PubMed  Google Scholar 

  3. Moore ES, Coe FL, McMann BJ, Favus MJ (1978) Idiopathic hypercalciuria in children: prevalence and metabolic characteristics. J Pediatr 92:906–910

    Article  PubMed  CAS  Google Scholar 

  4. Spivacow FR, Negri AL, del Valle EE, Calvino I, Zanchetta JR (2010) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475

    Article  PubMed  Google Scholar 

  5. Frick KK, Bushinsky DA (2003) Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14:1082–1095

    Article  PubMed  Google Scholar 

  6. Zerwekh JE (2010) Bone disease and hypercalciuria in children. Pediatr Nephrol 25:395–401

    Article  PubMed  Google Scholar 

  7. Zerwekh JE (2008) Bone disease and idiopathic hypercalciuria. Semin Nephrol 28:133–142

    Article  PubMed  Google Scholar 

  8. Weisinger JR, Alonzo E, Carlini RG, Paz-Martinez V, Martinis R, Bellorin-Font E (1998) Bone disease in hypercalciuria: a new form of osteodystrophy? Nephrol Dial Transplant 13 [Suppl 3]:88–90

    Article  PubMed  Google Scholar 

  9. Weisinger JR (1996) New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 49:1507–1518

    Article  PubMed  CAS  Google Scholar 

  10. Tasca A, Dalle Carbonare L, Nigro F, Giannini S (2009) Bone disease in patients with primary hypercalciuria and calcium nephrolithiasis. Urology 74:22–27

    Article  PubMed  Google Scholar 

  11. Skalova S, Palicka V, Kutilek S (2005) Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology (Carlton) 10:99–102

    Article  CAS  Google Scholar 

  12. Schwaderer AL, Cronin R, Mahan JD, Bates CM (2008) Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol 23:2209–2214

    Article  PubMed  Google Scholar 

  13. Polito C, Iolascon G, Nappi B, Andreoli S, La Manna A (2003) Growth and bone mineral density in long-lasting idiopathic hypercalciuria. Pediatr Nephrol 18:545–547

    PubMed  Google Scholar 

  14. Giannini S, Nobile M, Sella S, Dalle Carbonare L (2005) Bone disease in primary hypercalciuria. Crit Rev Clin Lab Sci 42:229–248

    Article  PubMed  CAS  Google Scholar 

  15. Garcia-Nieto V, Ferrandez C, Monge M, de Sequera M, Rodrigo MD (1997) Bone mineral density in pediatric patients with idiopathic hypercalciuria. Pediatr Nephrol 11:578–583

    Article  PubMed  CAS  Google Scholar 

  16. Garcia-Nieto V, Navarro JF, Ferrandez C (1998) Bone loss in children with idiopathic hypercalciuria. Nephron 78:341–342

    Article  PubMed  CAS  Google Scholar 

  17. Penido MG, Lima EM, Souto MF, Marino VS, Tupinamba AL, Franca A (2006) Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria? Pediatr Nephrol 21:74–78

    Article  PubMed  Google Scholar 

  18. Penido MG, Lima EM, Marino VS, Tupinamba AL, Franca A, Souto MF (2003) Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18:133–139

    PubMed  Google Scholar 

  19. Pfeilschifter J, Chenu C, Bird A, Mundy GR, Roodman GD (1989) Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res 4:113–118

    Article  PubMed  CAS  Google Scholar 

  20. Weisinger JR, Alonzo E, Bellorin-Font E, Blasini AM, Rodriguez MA, Paz-Martinez V, Martinis R (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244–250

    Article  PubMed  CAS  Google Scholar 

  21. Gowen M, Mundy GR (1986) Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 136:2478–2482

    PubMed  CAS  Google Scholar 

  22. Gomes SA, dos Reis LM, Noronha IL, Jorgetti V, Heilberg IP (2008) RANKL is a mediator of bone resorption in idiopathic hypercalciuria. Clin J Am Soc Nephrol 3:1446–1452

    Article  PubMed  Google Scholar 

  23. Freundlich M, Alonzo E, Bellorin-Font E, Weisinger JR (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17:1396–1401

    Article  PubMed  Google Scholar 

  24. Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, Wajchemberg BL, Jorgetti V (2002) Bone involvement in idiopathic hypercalciuria. Clin Nephrol 57:183–191

    PubMed  CAS  Google Scholar 

  25. Santos ACS Jr, Lima EM, Oliveira EA, Simões e Silva AC (2011) Bone disease and cytokines in idiopathic hypercalciuria: a review. J Pediatr Endocrinol Metab 24:405–410

    Article  PubMed  Google Scholar 

  26. Butani L, Kalia A (2004) Idiopathic hypercalciuria in children—how valid are the existing diagnostic criteria? Pediatr Nephrol 19:577–582

    Article  PubMed  Google Scholar 

  27. Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Invest 115:2598–2608

    Article  PubMed  CAS  Google Scholar 

  28. Hughes P (2007) The CARI guidelines. Kidney stones: metabolic evaluation. Nephrology (Carlton) 12 [Suppl 1]:31–33

    Article  Google Scholar 

  29. Lewiecki EM, Gordon CM, Baim S, Leonard MB, Bishop NJ, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S (2008) International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone 43:1115–1121

    Article  PubMed  Google Scholar 

  30. Brandao CM, Camargos BM, Zerbini CA, Plapler PG, Mendonca LM, Albergaria BH, Pinheiro MM, Prado M, Eis SR (2009) 2008 official positions of the Brazilian Society for Clinical Densitometry—SBDens. Arq Bras Endocrinol Metabol 53:107–112

    Article  PubMed  Google Scholar 

  31. Baroncelli GI, Bertelloni S, Sodini F, Saggese G (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs 7:295–323

    Article  PubMed  Google Scholar 

  32. Souto MF, Teixeira AL, Russo RC, Penido MG, Silveira KD, Teixeira MM, Simoes e Silva AC (2008) Immune mediators in idiopathic nephrotic syndrome: evidence for a relation between interleukin 8 and proteinuria. Pediatr Res 64:637–642

    Article  PubMed  CAS  Google Scholar 

  33. Volejnikova S, Laskari M, Marks SC Jr, Graves DT (1997) Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse. Am J Pathol 150:1711–1721

    PubMed  CAS  Google Scholar 

  34. Yadav A, Saini V, Arora S (2010) MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 411:1570–1579

    Article  PubMed  CAS  Google Scholar 

  35. Posner LJ, Miligkos T, Gilles JA, Carnes DL, Taddeo DR, Graves DT (1997) Monocyte chemoattractant protein-1 induces monocyte recruitment that is associated with an increase in numbers of osteoblasts. Bone 21:321–327

    Article  PubMed  CAS  Google Scholar 

  36. Lorenzo J, Horowitz M, Choi Y (2008) Osteoimmunology: interactions of the bone and immune system. Endocr Rev 29:403–440

    Article  PubMed  CAS  Google Scholar 

  37. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 16:1787–1794

    Article  PubMed  CAS  Google Scholar 

  38. Pacifici R (2010) The immune system and bone. Arch Biochem Biophys 503:41–53

    Article  PubMed  CAS  Google Scholar 

  39. Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K (1990) Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 71:138–145

    Article  PubMed  CAS  Google Scholar 

  40. Giannini S, Nobile M, Sartori L, Dalle Carbonare L, Ciuffreda M, Corrò P, D’Angelo A, Calò L, Crepaldi G (1999) Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 69:267–271

    PubMed  CAS  Google Scholar 

  41. Shroff R, Knott C, Rees L (2010) The virtues of vitamin D—but how much is too much? Pediatr Nephrol 25:1607–1620

    Article  PubMed  Google Scholar 

  42. Soylemezoglu O, Ozkaya O, Gonen S, Misirlioglu M, Kalman S, Buyan N (2004) Vitamin D receptor gene polymorphism in hypercalciuric children. Pediatr Nephrol 19:724–727

    Article  PubMed  Google Scholar 

  43. Borges JL, Brandao CM (2006) Low bone mass in children and adolescents. Arq Bras Endocrinol Metabol 50:775–782

    Article  PubMed  Google Scholar 

  44. Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, Prin L, Fournier A (1997) Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 82:32–38

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was partially supported by CNPq (Brazilian National Research Council) and FAPEMIG (Foundation of Research Support of Minas Gerais). Dr. A.C. Simões e Silva, Dr. E.A. Oliveira, Dr E.M. Lima, and Dr. M.M. Teixeira had a scientific productivity grant from the CNPq. Dr. A.C. Simões e Silva and Dr. E.A. Oliveira also received the Grant INCT-MM (FAPEMIG: CBB-APQ-00075-09 / CNPq 573646/2008-2).

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ana Cristina Simões e Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, A.C.S., Lima, E.M., Penido, M.G.M.G. et al. Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria. Pediatr Nephrol 27, 941–948 (2012). https://doi.org/10.1007/s00467-011-2094-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-2094-4

Key words

Navigation